Validation of COMPAT-SF Spanish Translation
1 other identifier
observational
100
1 country
1
Brief Summary
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 13, 2024
CompletedFirst Submitted
Initial submission to the registry
November 18, 2024
CompletedFirst Posted
Study publicly available on registry
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 13, 2026
November 20, 2024
July 1, 2024
2 years
November 18, 2024
November 18, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Face validity:
Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire
through study completion, up to 18 months
Interventions
Administer translated COMPAT-SF questionnaires to Spanish-speaking CP patients
Eligibility Criteria
Spanish speaking subjects with CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
You may qualify if:
- years or older in age
- Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
- Able to read and understand the study information in Spanish
- Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
- Subject is willing and able to comply with the scheduled questionnaires
You may not qualify if:
- Subjects who do not meet the criteria in section 4.1
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Methodist Health Systemlead
- Aalborg University Hospitalcollaborator
Study Sites (1)
Methodist Dallas Medical Center- Clinical Research Institute
Dallas, Texas, 75203, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2024
First Posted
November 20, 2024
Study Start
September 13, 2024
Primary Completion (Estimated)
September 13, 2026
Study Completion (Estimated)
September 13, 2026
Last Updated
November 20, 2024
Record last verified: 2024-07